Induction and activation of the aryl hydrocarbon receptor by IL-4 in B cells

International Immunology

Volumn 17, Issue 6, 2005, Pages 797-805

  Tanaka, Go ^a   Kanaji, Sachiko ^a   Hirano, Ayumi ^b   Arima, Kazuhiko ^a   Shinagawa, Akira ^b   Goda, Chiho ^a   Yasunaga, Shin'ichiro ^a   Ikizawa, Koichi ^c   Yanagihara, Yukiyoshi ^d   Kubo, Masato ^e   Kuriyama Fujii, Yoshiaki ^f   Sugita, Yuji ^b   Inokuchi, Akira ^a   Izuhara, Kenji ^a  

^a SAGA UNIVERSITY   (Japan)

^b Genox Research Inc   (Japan)

^c TAIHO PHARMACEUTICAL CO LTD   (Japan)

^d SAGAMIHARA NATIONAL HOSPITAL   (Japan)

^e RIKEN Center for Integrative Medical Sciences   (Japan)

^f UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

CYP1A1; Dioxin; Gene regulation; Microarray; Xenobiotics

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; CD23 ANTIGEN; CYTOCHROME P450 1A1; GENE PRODUCT; GENOMIC DNA; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; LIGAND; PROTEASOME; STAT6 PROTEIN; XENOBIOTIC AGENT;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; BURKITT LYMPHOMA; CELL NUCLEUS; CONTROLLED STUDY; DNA MICROARRAY; GENE ACTIVATION; GENE IDENTIFICATION; GENE INDUCTION; GENE TECHNOLOGY; GENE TRANSLOCATION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; LYMPHOMA CELL LINE; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; XENOBIOTIC METABOLISM; ANIMAL; B CELL LYMPHOMA; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL LINE; DRUG EFFECT; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; METABOLISM; PLASMID; POLLUTANT; TUMOR CELL LINE;

ANIMALS; BURKITT LYMPHOMA; CELL LINE; CELL LINE, TUMOR; CELL NUCLEUS; CYTOCHROME P-450 CYP1A1; ENVIRONMENTAL POLLUTANTS; HUMANS; INTERLEUKIN-13; INTERLEUKIN-4; LYMPHOMA, B-CELL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PLASMIDS; RECEPTORS, ARYL HYDROCARBON; TETRACHLORODIBENZODIOXIN; TRANSFECTION;

EID: 26444493215     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxh260     Document Type: Article

References (33)

1. Izuhara, K., Arima, K. and Yasunaga, S. 2002. IL-4 and IL-13: Their pathological roles in allergic diseases and their potential in developing new therapies. Curr. Drug Targets Inflamm. Allergy 1:263.
2. Zurawski, G. and de Vries, J. E. 1994. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol. Today 15:19.
3. Chomarat, P. and Banchereau, J. 1998. Interleukin-4 and interleukin-13: their similarities and discrepancies. Int. Rev. Immunol. 17:1.
4. de Vries, J. E. 1998. The role of IL-13 and its receptor in allergy and inflammatory responses. J. Allergy Clin. Immunol. 102:165.
5. Kay, N. E. and Pittner, B. T. 2003. IL-4 biology: Impact on normal and leukemic CLL B cells. Leuk. Lymphoma 44:897.
6. Takenaka, H., Zhang, K., Diaz-Sanchez, D., Tsien, A. and Saxon, A. 1995. Enhanced human IgE production results from exposure to the aromatic hydrocarbons from diesel exhaust: Direct effects on B-cell IgE production. J. Allergy Clin. Immunol. 95:103.
7. Kimata, H. 2003. 2,3,7,8-Tetrachlorodibenzo-p-dioxin selectively enhances spontaneous IgE production in B cells from atopic patients. Int. J. Hyg. Environ. Health 206:601.
8. Sogawa, K. and Fujii-Kuriyama, Y. 1997. Ah receptor, a novel ligand-activated transcription factor. J. Biochem. (Tokyo) 122:1075.
9. Schmidt, J. V. and Bradfield, C. A. 1996. Ah receptor signaling pathways. Annu. Rev. Cell Dev. Biol. 12:55.
10. Puga, A., Xia, Y. and Elferink, C. 2002. Role of the aryl hydrocarbon receptor in cell cycle regulation. Chem. Biol. Interact. 141:117.
11. Tian, Y., Rabson, A. B. and Gallo, M. A. 2002. Ah receptor and NF-κB interactions: Mechanisms and physiological implications. Chem. Biol. Interact. 141:97.
12. Umeshita-Suyama, R., Sugimoto, R., Akaiwa, M. et al. 2000. Characterization of IL-4 and IL-13 signals dependent on the human IL-13 receptor a chain 1: Redundancy of requirement of tyrosine residue for STAT3 activation. Int. Immunol. 12:1499.
13. Yuyama, N., Davies, D. E., Akaiwa, M. et al. 2002. Analysis of novel disease-related genes in bronchial asthma. Cytokine 19:287.
14. Izuhara, K., Heike, T., Otsuka, T. et al. 1996. Signal transduction pathway of interleukin-4 and interleukin-13 in human B cells derived from X-linked severe combined immunodeficiency patients. J. Biol. Chem. 271:619.
15. Yagi, R., Nagai, H., Iigo, Y., Akimoto, T., Arai, T. and Kubo, M. 2002. Development of atopic dermatitis-like skin lesions in STAT6-deficient NC/ Nga mice. J. Immunol. 168:2020.
16. Mimura, J., Yamashita, K., Nakamura, K. et al. 1997. Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes Cells 2:645.
17. Yasunaga, S., Yuyama, N., Arima, K. et al. 2003. The negative-feedback regulation of the IL-13 signal by the IL-13 receptor α2 chain in bronchial epithelial cells. Cytokine 24:293.
18. Gaff, C., Grumont, R. J. and Gerondakis, S. 1992. Transcriptional regulation of the germline immunoglobulin C α and C E genes: implications for commitment to an isotype switch. Int. Immunol. 4:1145.
19. Yokota, A., Kikutani, H., Tanaka, T. et al. 1988. Two species of human Fc E receptor II (Fc E RII/CD23): Tissue-specific and IL-4-specific regulation of gene expression. Cell 55:611.
20. Marcus, R. S., Holsapple, M. P. and Kaminski, N. E. 1998. Lipopolysaccharide activation of murine splenocytes and splenic B cells increased the expression of aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator. J. Pharmacol. Exp. Ther. 287:1113.
21. Takeda, K., Tanaka, T., Shi, W. et al. 1996. Essential role of Stat6 in IL-4 signaling. Nature 380:627.
22. Shimoda, K., van Deursen, J., Sangster, M. Y. et al. 1996. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380:630.
23. Davarinos, N. A. and Pollenz, R. S. 1999. Aryl hydrocarbon receptor imported into the nucleus following ligand binding is rapidly degraded via the cytosplasmic proteasome following nuclear export. J. Biol. Chem. 274:28708.
24. Roberts, B. J. and Whitelaw, M. L. 1999. Degradation of the basic helix-loop-helix/Per-ARNT-Sim homology domain dioxin receptor via the ubiquitin/proteasome pathway. J. Biol. Chem. 274:36351.
25. Ma, Q. and Baldwin, K. T. 2000. 2,3,7,8-Tetrachlorodibenzo-p dioxin-induced degradation of aryl hydrocarbon receptor (AhR) by the ubiquitin-proteasome pathway. Role of the transcription activaton and DNA binding of AhR. J. Biol. Chem. 275:8432.
26. Wills-Karp, M. and Chiaramonte, M. 2003. Interleukin-13 in asthma. Curr. Opin. Pulm. Med. 9:21.
27. Lee, J. H., Kaminski, N., Dolganov, G. et al. 2001. Interleukin-13 induces dramatically different transcriptional programs in three human airway cell types. Am. J. Respir. Cell Mol. Biol. 25:474.
28. Syed, F., Panettieri, R. A., Jr, Tliba, O. et al. 2005. The effect of IL-13 and IL-13R130Q, a naturally occurring IL-13 polymorphism, on the gene expression of human airway smooth muscle cells. Respir. Res. 6:9.
29. Welch, J. S., Escoubet-Lozach, L., Sykes, D. B., Liddiard, K., Greaves, D. R. and Glass, C. K. 2002. TH2 cytokines and allergic challenge induce Ym1 expression in macrophages by a STAT6-dependent mechanism. J. Biol. Chem. 277:42821.
30. Zou, J., Young, S., Zhu, F. et al. 2002. Microarray profile of differentially expressed genes in a monkey model of allergic asthma. Genome Biol. 3:rEsearch0020.1.
31. Lorenzen, A. and Okey, A. B. 1991. Detection and characterization of Ah receptor in tissue and cells from human tonsils. Toxicol. Appl. Pharmacol. 107:203.
32. Takeda, K., Kamanaka, M., Tanaka, T., Kishimoto, T. and Akira, S. 1996. Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice. J. Immunol. 157:3220.
33. Santiago-Josefat, B., Pozo-Guisado, E., Mulero-Navarro, S. and Fernandez-Salguero, P. M. 2001. Proteasome inhibition induces nuclear translocation and transcriptional activation of the dioxin receptor in mouse embryo primary fibroblasts in the absence of xenobiotics. Mol. Cell. Biol. 21:1700.